A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease

Heart Lung Circ. 2008 Feb;17(1):14-8. doi: 10.1016/j.hlc.2007.05.009. Epub 2007 Jun 19.

Abstract

Purpose: The aim of this study was to investigate whether the variability between individuals with coronary heart disease (CHD) is related to the prevalence of TNF-alpha gene promoter -308 variant in un-matched British Caucasian population from East Midlands.

Procedures: Genotypes and allele frequencies were determined using restriction fragment length polymorphism analysis of polymerase chain reaction (PCR) products. Genomic DNA prepared from peripheral blood leukocytes of patients (n=97) and healthy controls (n=95) demonstrated two alleles TNF*1 (G) and TNF*2 (A).

Findings: The genotype distribution in patients was GG, n=59; GA, n=36; and AA, n=2 and in controls was GG, n=41; GA, n=40; and AA, n=14 (P=0.014). The association analysis demonstrated that TNF*1 allele in patients appears to be associated with greater incidences of CHD (OR 2.15; CI, 1.36-3.39; P=0.001).

Conclusions: Our results suggest that TNF*1 allele (TNF-alpha -308 GG or GA) has a high prevalence among British Caucasian population that correlates with an increased CHD risk.

MeSH terms

  • Age Distribution
  • Aged
  • Case-Control Studies
  • Confidence Intervals
  • Coronary Angiography
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / epidemiology*
  • Coronary Disease / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / epidemiology*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Odds Ratio
  • Pilot Projects
  • Polymorphism, Genetic*
  • Probability
  • Prognosis
  • Promoter Regions, Genetic
  • Reference Values
  • Risk Assessment
  • Sex Distribution
  • Tumor Necrosis Factor-alpha / genetics*
  • United Kingdom / epidemiology
  • White People / genetics*

Substances

  • Tumor Necrosis Factor-alpha